Cost effectiveness of drug eluting coronary artery stenting in a UK setting: cost–utility study

Abstract

At current UK prices, DES are not cost effective compared with conventional stents except for a small minority of patients. Although the technology is clearly effective, general substitution is not justified unless the price premium falls substantially.